Back to Agendas
Taking the Pulse of Outsourcing Relationship Structures and Their Impact
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Center For the Study of Drug Development, United States
This session examines the results and implications of a recent study conducted by the Tufts Center for the Study of Drug Development (Tufts CSDD) that looked at 43 phase 2 and 3 clinical studies completed since 2012 to evaluate actual sponsor company outsourcing practices. The study also performed an in-depth assessment of sponsor company attitudes and perceptions about their current and future outsourcing strategies. Study results indicate that sponsor companies are inconsistently mixing and matching relationship models on a study-by-study basis and that they are planning a number of major changes to their outsourcing strategies and practices.
Learning Objective : Review trends in outsourcing relationship models including ways that biopharmaceutical companies have modified operating structures to accommodate more strategic relationships; Explain why strategic relationships are not driving higher levels of efficiency, lower cost and faster study cycle time; Discuss new approaches to better leverage the value of strategic outsourcing relationships.
Speaker(s)
Review and Discussion of the Study Results and Their Implications
Frances Grote, MBA
Biogen Inc., United States
Senior Director, Clinical Operations Vendor Oversight
Review and Discussion of Study Results and Their Implications
Kenneth Getz, MBA
Center For the Study of Drug Development, United States
Tufts Center for the Study of Drug Development
Have an account?